Gaithersburg, Maryland-based MedImmune has received the Food and Drug Administration’s approval for self- or caregiver-administration of its FluMist nasal spray flu vaccine, meaning no physician needed. It is expected to be available through online pharmacies beginning next year. FluMist still needs a prescription and is approved for home administration for individuals 2 to 49 years old.
FDA approves FluMist nasal spray flu vaccine — no doctor required
October 2, 2024